Tag: Instylla
Instylla announces completion of financing round
Instylla, a company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the closing of a US$30 million financing round.
This financing round...
Instylla announces positive results from preclinical studies of Embrace hydrogel embolic...
Instylla, a company developing liquid embolics for peripheral vascular embolotherapy, recently announced two publications that evaluated the Embrace hydrogel embolic system (HES) in preclinical...
Instylla first-in-human clinical trial published results demonstrate success
A prospective multicentre study has evaluated the safety and efficacy of a polyethylene glycol (PEG)-based liquid embolic in treating hypervascular tumours, according to an...
First patients enrolled in the Embrace hydrogel embolic system global randomised...
The initial patients have been enrolled in the Embrace hydrogel embolic system (HES) global randomised clinical trial for the treatment of hypervascular tumours, Instylla...
